These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18860173)

  • 21. Vector Competence of Anopheles kleini and Anopheles sinensis (Diptera: Culicidae) From the Republic of Korea to Vivax Malaria-Infected Blood From Patients From Thailand.
    Ubalee R; Kim HC; Schuster AL; McCardle PW; Phasomkusolsil S; Takhampunya R; Davidson SA; Lee WJ; Klein TA
    J Med Entomol; 2016 Nov; 53(6):1425-1432. PubMed ID: 27493248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria.
    ALVING AS
    Abstr Int Congr Trop Med Malar; 1948; 56(4th Congr):58. PubMed ID: 18872928
    [No Abstract]   [Full Text] [Related]  

  • 23. False positive tests for syphilis; a further study of their incidence in sporozoite-induced vivax malaria.
    KENT JF; CULWELL WB
    J Lab Clin Med; 1948 Jun; 33(6):747-52. PubMed ID: 18865752
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies in human malaria; the protective and therapeutic action of SN 6911 against St. Elizabeth strain vivax malaria.
    RUHE DS; COOPER WC
    Am J Hyg; 1949 Jan; 49(1):41-8. PubMed ID: 18108519
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies in human malaria; the therapeutic action of pamaquine against St. Elizabeth strain vivax malaria.
    RUHE DS; COOPER WC
    Am J Hyg; 1949 May; 49(3):367-73. PubMed ID: 18121216
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies in human malaria; the cure of St. Elizabeth strain vivax malaria by pentaquine-quinine, administered during acute attacks or during latency.
    WHITE WC; COOPER WC
    J Natl Malar Soc; 1948 Dec; 7(4):316-21. PubMed ID: 18109266
    [No Abstract]   [Full Text] [Related]  

  • 27. Distribution of malaria vectors and incidence of vivax malaria at Korean army installations near the demilitarized zone, Republic of Korea.
    Chang KS; Yoo DH; Ju YR; Lee WG; Roh JY; Kim HC; Klein TA; Shin EH
    Malar J; 2016 May; 15(1):259. PubMed ID: 27150110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloroquine or pyrimethamine in salt as a supressive against sporozoite-induced vivax malaria (Chesson strain).
    COATNEY GR; MICKELSEN O; BURGESS RW; YOUNG MD; PIRKLE CI
    Bull World Health Organ; 1958; 19(1):53-67. PubMed ID: 13585060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VIABILITY AND INFECTIVITY OF CRYOPRESERVED PLASMODIUM VIVAX SPOROZOITES.
    Patrapuvich R; Lerdpanyangam K; Jenwithisuk R; Rungin S; Boonhok R; Duangmanee A; Yimamnuaychok N; Sattabongkot J
    Southeast Asian J Trop Med Public Health; 2016 Mar; 47(2):171-81. PubMed ID: 27244953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
    Edstein MD; Walsh DS; Eamsila C; Sasiprapha T; Nasveld PE; Kitchener S; Rieckmann KH
    Med Trop (Mars); 2001; 61(1):56-8. PubMed ID: 11584657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of the curative action of 8-aminoquinolines and naphthoquinones in avian malaria.
    WALKER HA; RICHARDSON AP
    J Natl Malar Soc; 1948 Mar; 7(1):4-11. PubMed ID: 18908060
    [No Abstract]   [Full Text] [Related]  

  • 32. New tissue schizontocidal antimalarial drugs.
    Davidson DE; Ager AL; Brown JL; Chapple FE; Whitmire RE; Rossan RN
    Bull World Health Organ; 1981; 59(3):463-79. PubMed ID: 6976854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
    Campo B; Vandal O; Wesche DL; Burrows JN
    Pathog Glob Health; 2015 May; 109(3):107-22. PubMed ID: 25891812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.
    Alves E; Salman AM; Leoratti F; Lopez-Camacho C; Viveros-Sandoval ME; Lall A; El-Turabi A; Bachmann MF; Hill AV; Janse CJ; Khan SM; Reyes-Sandoval A
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-assessing the relationship between sporozoite dose and incubation period in Plasmodium vivax malaria: a systematic re-analysis.
    Lover AA; Coker RJ
    Parasitology; 2014 May; 141(6):859-68. PubMed ID: 24524462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
    Fink E
    Bull World Health Organ; 1974; 50(3-4):213-22. PubMed ID: 4155355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observations on the biological nature of Plasmodium vivax sporozoites.
    Collins WE; Sullivan JS; Morris CL; Galland GG; Richardson BB
    J Parasitol; 1996 Apr; 82(2):216-9. PubMed ID: 8604086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pamaquin; curative antimalarial activity in vivax malaria.
    BERLINER RW; TAGGART JV
    Fed Proc; 1946; 5(1 Pt 2):165. PubMed ID: 21064280
    [No Abstract]   [Full Text] [Related]  

  • 39. Cure of chronic vivax malaria with pentaquine.
    COGGESHALL LT; RICE FA
    J Am Med Assoc; 1949 Feb; 139(7):437-9. PubMed ID: 18123173
    [No Abstract]   [Full Text] [Related]  

  • 40. Malaria chemotherapy; the response of sporozoite-induced infections with Plasmodium cynomolgi to various antimalarial drugs.
    SCHMIDT LH; FRADKIN R
    Fed Proc; 1948 Mar; 7(1 Pt 1):253. PubMed ID: 18934432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.